Murphy & Mullick Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.3K Sell
525
-14
-3% -$1.25K 0.03% 287
2026
Q1
$38.7K Buy
539
+26
+5% +$2K 0.03% 317
2025
Q4
$40.7K Sell
513
-86
-14% -$6.78K 0.03% 322
2025
Q3
$45.2K Sell
599
-631
-51% -$43.2K 0.03% 291
2025
Q2
$76.7K Sell
1,230
-156
-11% -$10.2K 0.06% 215
2025
Q1
$93.9K Sell
1,386
-10
-0.7% -$598 0.09% 182
2024
Q4
$62.7K Buy
+1,396
New +$78.3K 0.06% 230

Other funds holding CVS

Murphy & Mullick Capital Management's CVS Position: Q2 2026 in Review

Murphy & Mullick Capital Management reduced its CVS Health (CVS) stake by 2.6% in Q2 2026, selling an estimated $1.25K and leaving 525 shares worth $54.3K. The position accounts for 0.03% of the portfolio, ranked #287.

Murphy & Mullick Capital Management first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. The position peaked at $93.9K in Q1 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Murphy & Mullick Capital Management held 525 shares of CVS Health worth $54.3K as of Q2 2026.
  • Murphy & Mullick Capital Management sold 14 CVS Health shares in Q2 2026, an estimated $1.25K.
  • CVS Health made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #287 holding.
  • Murphy & Mullick Capital Management first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • Murphy & Mullick Capital Management's CVS Health position peaked at $93.9K in Q1 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.